InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,471.05
(
1.16%
)
US TECH 100
18,178.40
(
0.00%
)
Dow Jones
40,829.59
(
1.20%
)
Brent Oil
71.28
(
-0.61%
)
Bitcoin
56,842.74
(
-0.32%
)
Post# of 253075
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

pharmaclown35

Send PM Follow Ignore
Followers 1
Posts 202
Boards Moderated 0
Alias Born 01/23/2008

pharmaclown35

Re: None

Saturday, 04/10/2010 10:31:04 PM

Saturday, April 10, 2010 10:31:04 PM

Post# of 253075
competing drug to Acorda's Amprya - Sanofi Aventis will announce nerispridine results in 3Q2010. this will be really interesting to watch...apparently their drug may have less seizure risk. but will have to see the results.

is anyone on this board at AAN right now?? or following it. any major updates from this conference?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up